JPRN-UMIN000018269
Completed
未知
A study to evaluate the effect of decreasing serum uric acid level by ingestion of botanical ingredient-containing foods - A study to evaluate the effect of decreasing serum uric acid level by ingestion of botanical ingredient-containing foods
ew Drug Research Center, Inc.0 sites75 target enrollmentJuly 13, 2015
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- ew Drug Research Center, Inc.
- Enrollment
- 75
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) With gouty arthritis and gouty arthritis. 2\) With high serum uric acid level (\>\= 8\.0 mg/dL) and kidney damage, urinary stone, hypertension, ischemic cardiac disease, diabetes, metabolic syndrome. 3\) Use of product affecting the data of this study, such as medicine, food for specified health use, supplement, diet food. 4\) Female in pregnancy, lactation and scheduled pregnancy period. 5\) Investigator's judgment for other reason.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 3
Effect of serum on the complications of third Molar surgeryMandibular third molar surgery.Supernumerary teethK00.1IRCT20191127045516N3Kermanshah University of Medical Sciences300
Completed
Phase 3
A prospective study of the impact upon serum electrolyte and magnesium levels of using magnesium sulfate for bowel preparation for colonoscopy.ColonoscopyOral and Gastrointestinal - Normal oral and gastrointestinal development and functionACTRN12608000160336Colocap Pharmaceuticals100
Completed
Not Applicable
Effect of weight loss on inflammatory indicators in obese patients with fatty liver diseaseFatty liver.Fatty (change of) liverIRCT2014030515105N2Vice chancellor for research, Tabriz University of Medical Sciences40
Completed
Not Applicable
A study to confirm the reduction effect of the test food on abdominal visceral fat. -Randomized, double-blind, placebo-controlled parallel group studyJPRN-UMIN000051265ew drug research center, Inc.44
Not yet recruiting
Not Applicable
A clinical study to assess response of a drug that treats low red blood cells count in chronic kidney disease patientsHealth Condition 1: N183- Chronic kidney disease, stage 3 (moderate)Health Condition 2: N184- Chronic kidney disease, stage 4 (severe)Health Condition 3: N185- Chronic kidney disease, stage 5Health Condition 4: N186- End stage renal diseaseCTRI/2024/01/060994BHAWNA SAINI